Multiple single nucleotide polymorphisms in the first intron of the IL2RA gene affect transcription factor binding and enhancer activity.

IL2RA gene encodes the alpha subunit of a high-affinity receptor for interleukin-2 which is expressed by several distinct populations of lymphocytes involved in autoimmune processes. A large number of polymorphic alleles of the IL2RA locus are associated with the development of various autoimmune diseases. With bioinformatics analysis we the dissected the first intron of the IL2RA gene and selected several single nucleotide polymorphisms (SNPs) that may influence the regulation of the IL2RA gene in cell types relevant to autoimmune pathology. We described five enhancers containing the selected SNPs that stimulated activity of the IL2RA promoter in a cell-type specific manner, and tested the effect of specific SNP alleles on activity of the respective enhancers (E1 to E5, labeled according to the distance to the promoter). The E4 enhancer with minor T variant of rs61839660 SNP demonstrated reduced activity due to disrupted binding of MEF2A/C transcription factors (TFs). Neither rs706778 nor rs706779 SNPs, both associated with a number of autoimmune diseases, had any effect on the activity of the enhancer E2. However, rare variants of several SNPs (rs139767239, rs115133228, rs12722502, rs12722635) genetically linked to either rs706778 and/or rs706779 significantly influenced the activity of E1, E3 and E5 enhancers, presumably by disrupting EBF1, GABPA and ELF1 binding sites.

[1]  J. Todd,et al.  Association of the interleukin‐2 receptor alpha (IL‐2Rα)/CD25 gene region with Graves’ disease using a multilocus test and tag SNPs , 2007, Clinical endocrinology.

[2]  Xavier Montalban,et al.  Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta , 2010, The Lancet Neurology.

[3]  Brian T. Lee,et al.  The UCSC Genome Browser database: 2015 update , 2014, Nucleic Acids Res..

[4]  Jo Lambert,et al.  Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. , 2010, The New England journal of medicine.

[5]  David E. Anderson,et al.  IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production , 2009, PLoS genetics.

[6]  John A. Todd,et al.  Proteome-Wide Analysis of Disease-Associated SNPs That Show Allele-Specific Transcription Factor Binding , 2012, PLoS genetics.

[7]  Jacques van Helden,et al.  Regulatory Sequence Analysis Tools , 2003, Nucleic Acids Res..

[8]  Marta E Alarcón-Riquelme,et al.  Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci , 2008, Nature Genetics.

[9]  B. Deplancke,et al.  The Genetics of Transcription Factor DNA Binding Variation , 2016, Cell.

[10]  A. Verma,et al.  Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study , 2008 .

[11]  M. Daly,et al.  Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.

[12]  Mark Atkinson,et al.  Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes , 2007, Nature Genetics.

[13]  K. Furuuchi,et al.  Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer , 2008, Nature Immunology.

[14]  S. Sánchez-Ramón,et al.  New regulatory CD19+CD25+ B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids , 2014, Journal of Neuroimmunology.

[15]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[16]  M. McCarthy,et al.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.

[17]  Shane J. Neph,et al.  Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.

[18]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[19]  David E. Anderson,et al.  Soluble IL-2RA Levels in Multiple Sclerosis Subjects and the Effect of Soluble IL-2RA on Immune Responses1 , 2009, The Journal of Immunology.

[20]  Jing Cui,et al.  Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci , 2010, Nature Genetics.

[21]  B. Bielekova,et al.  Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis , 2012, Science Translational Medicine.

[22]  Vsevolod J. Makeev,et al.  PERFECTOS-APE - Predicting Regulatory Functional Effect of SNPs by Approximate P-value Estimation , 2015, BIOINFORMATICS.

[23]  Denis Thieffry,et al.  RSAT 2015: Regulatory Sequence Analysis Tools , 2015, Nucleic Acids Res..

[24]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[25]  E. Rothenberg,et al.  Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. , 1999, Development.

[26]  P. Bucher,et al.  Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene , 1997, Molecular and cellular biology.

[27]  Pablo Moscato,et al.  Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 , 2009, Nature Genetics.

[28]  Yitao Wang,et al.  Characterization of MT-2 cells as a human regulatory T cell-like cell line , 2014, Cellular and Molecular Immunology.

[29]  Andre Franke,et al.  1000 Genomes-based imputation identifies novel and refined associations for the Wellcome Trust Case Control Consortium phase 1 Data , 2012, European Journal of Human Genetics.

[30]  Judy H. Cho,et al.  Finding the missing heritability of complex , 2009 .

[31]  I. Miyoshi,et al.  A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells. , 1981, Gan.

[32]  K. V. Korneev,et al.  Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells. , 2016, Biochimica et biophysica acta.

[33]  G. Bornkamm,et al.  Characterization of EBV‐genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non‐Hodgkin lymphoma , 1977, International journal of cancer.

[34]  W. Alkema,et al.  Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling , 2012, BMC Immunology.

[35]  S. Sakaguchi,et al.  The dichotomous role of IL-2: tolerance versus immunity. , 2006, Trends in immunology.

[36]  Vladimir B. Bajic,et al.  HOCOMOCO: expansion and enhancement of the collection of transcription factor binding sites models , 2015, Nucleic Acids Res..

[37]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[38]  R. Tjian,et al.  MEF2C and EBF1 Co-regulate B Cell-Specific Transcription , 2016, PLoS genetics.

[39]  Annette Lee,et al.  Genome-wide association study in alopecia areata implicates both innate and adaptive immunity , 2010, Nature.